Kim CW - Search Results

1

T/Tn immunotherapy avoiding immune deviation.

Son HY, Apostolopoulos V, Kim CW. Son HY, et al. Among authors: kim cw. Int J Immunopathol Pharmacol. 2016 Dec;29(4):812-817. doi: 10.1177/0394632016674018. Epub 2016 Oct 19. Int J Immunopathol Pharmacol. 2016. PMID: 27760846 Free PMC article.

2

Exosomes: a new delivery system for tumor antigens in cancer immunotherapy.

Cho JA, Yeo DJ, Son HY, Kim HW, Jung DS, Ko JK, Koh JS, Kim YN, Kim CW. Cho JA, et al. Among authors: kim hw, kim cw, kim yn. Int J Cancer. 2005 Apr 20;114(4):613-22. doi: 10.1002/ijc.20757. Int J Cancer. 2005. PMID: 15609328 Free article.

3

In vivo monitoring of transfected DNA, gene expression kinetics, and cellular immune responses in mice immunized with a human NIS gene-expressing plasmid.

Son HY, Jeon YH, Chung JK, Kim CW. Son HY, et al. Among authors: kim cw. Int J Immunopathol Pharmacol. 2016 Dec;29(4):612-625. doi: 10.1177/0394632016659493. Epub 2016 Sep 9. Int J Immunopathol Pharmacol. 2016. PMID: 27612483 Free PMC article.

4

Mannosylated T/Tn with Freund's adjuvant induces cellular immunity.

Son HY, Apostolopoulos V, Kim CW. Son HY, et al. Among authors: kim cw. Int J Immunopathol Pharmacol. 2018 Jan-Dec;31:394632017742504. doi: 10.1177/0394632017742504. Epub 2017 Dec 18. Int J Immunopathol Pharmacol. 2018. PMID: 29251002 Free PMC article.

5

MUC1 expressing tumor growth was retarded after human mucin 1 (MUC1) plasmid DNA immunization.

Son HY, Jeong HK, Apostolopoulos V, Kim CW. Son HY, et al. Among authors: kim cw. Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221112358. doi: 10.1177/03946320221112358. Int J Immunopathol Pharmacol. 2022. PMID: 35839304 Free PMC article.

6

Protective efficacy of a plasmid DNA vaccine against transgene-specific tumors by Th1 cellular immune responses after intradermal injection.

Son HY, Apostolopoulos V, Chung JK, Kim CW, Park JU. Son HY, et al. Among authors: kim cw. Cell Immunol. 2018 Jul;329:17-26. doi: 10.1016/j.cellimm.2018.04.003. Epub 2018 Apr 9. Cell Immunol. 2018. PMID: 29653690

7

Oxidized and reduced mannan mediated MUC1 DNA immunization induce effective anti-tumor responses.

Tang CK, Sheng KC, Pouniotis D, Esparon S, Son HY, Kim CW, Pietersz GA, Apostolopoulos V. Tang CK, et al. Among authors: kim cw. Vaccine. 2008 Jul 23;26(31):3827-34. doi: 10.1016/j.vaccine.2008.05.008. Epub 2008 May 22. Vaccine. 2008. PMID: 18550230

8

Introduction of the CIITA gene into tumor cells produces exosomes with enhanced anti-tumor effects.

Lee YS, Kim SH, Cho JA, Kim CW. Lee YS, et al. Among authors: kim cw, kim sh. Exp Mol Med. 2011 May 31;43(5):281-90. doi: 10.3858/emm.2011.43.5.029. Exp Mol Med. 2011. PMID: 21464590 Free PMC article.

9

In vivo scintigraphic imaging of antitumor effects by combined radioiodine therapy and human sodium iodide symporter gene immunotherapy.

Choi Y, Jeon YH, Paik JH, Ko J, Choi DH, Chung JK, Kim CW. Choi Y, et al. Among authors: kim cw. Mol Imaging. 2010 Jun;9(3):141-52. Mol Imaging. 2010. PMID: 20487680

10

A novel chimeric DNA vaccine: enhancement of preventive and therapeutic efficacy of DNA vaccine by fusion of Mucin 1 to a heat shock protein 70 gene.

Choi DH, Woo JK, Choi Y, Seo HS, Kim CW. Choi DH, et al. Among authors: kim cw. Mol Med Rep. 2011 Sep-Oct;4(5):885-90. doi: 10.3892/mmr.2011.525. Epub 2011 Jul 1. Mol Med Rep. 2011. PMID: 21725596

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,045 results

Search Page